James E. Udelson

45.4k total citations · 17 hit papers
326 papers, 25.9k citations indexed

About

James E. Udelson is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, James E. Udelson has authored 326 papers receiving a total of 25.9k indexed citations (citations by other indexed papers that have themselves been cited), including 256 papers in Cardiology and Cardiovascular Medicine, 132 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Surgery. Recurrent topics in James E. Udelson's work include Cardiac Imaging and Diagnostics (125 papers), Cardiovascular Function and Risk Factors (104 papers) and Heart Failure Treatment and Management (85 papers). James E. Udelson is often cited by papers focused on Cardiac Imaging and Diagnostics (125 papers), Cardiovascular Function and Risk Factors (104 papers) and Heart Failure Treatment and Management (85 papers). James E. Udelson collaborates with scholars based in United States, Italy and Canada. James E. Udelson's co-authors include Barry J. Maron, Martin S. Maron, Marvin A. Konstam, Mark S. Link, Robert O. Bonow, Rick A. Nishimura, John R. Lesser, Warren J. Manning, Jeffrey A. Towbin and Natesa G. Pandian and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

James E. Udelson

311 papers receiving 25.1k citations

Hit Papers

2011 ACCF/AHA Guideline for the Diagnosis and Treatmen... 2002 2026 2010 2018 2011 2011 2002 2015 2006 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 1.6k citations Barry J. Maron, Robert O. Bonow et al. Circulation profile →
  2. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 869 citations Barry J. Maron, Robert O. Bonow et al. Journal of the American College of Cardiology profile →
  3. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
    2002 859 citations James E. Udelson et al. Journal of the American College of Cardiology profile →
  4. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
    2015 846 citations Pamela S. Douglas, Udo Hoffmann et al. profile →
  5. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
    2006 692 citations Martin S. Maron, Iacopo Olivotto et al. Circulation profile →
  6. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude
    2003 626 citations Jeffrey T. Kuvin, Ayan R. Patel et al. profile →
  7. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
    2011 585 citations Barry J. Maron, Robert O. Bonow et al. Circulation profile →
  8. Left Ventricular Remodeling in Heart Failure
    2011 552 citations Marvin A. Konstam, Daniel G. Kramer et al. profile →
  9. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
    2002 512 citations James E. Udelson et al. Circulation profile →
  10. Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance
    2008 464 citations Barry J. Maron, Evan Appelbaum et al. Journal of the American College of Cardiology profile →
  11. Relationship Between Infarct Size and Outcomes Following Primary PCI
    2016 425 citations Gregg W. Stone, Harry P. Selker et al. Journal of the American College of Cardiology profile →
  12. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
    2013 397 citations Andrew P. Ambrosy, Marvin A. Konstam et al. profile →
  13. High-Risk Plaque Detected on Coronary CT Angiography Predicts Acute Coronary Syndromes Independent of Significant Stenosis in Acute Chest Pain
    2014 362 citations Thomas Mayrhofer, Quynh A. Truong et al. Journal of the American College of Cardiology profile →
  14. Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain
    2018 328 citations Maros Ferencik, Thomas Mayrhofer et al. profile →
  15. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis
    2015 301 citations Barry J. Maron, James E. Udelson et al. Circulation profile →
  16. Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain
    2017 273 citations Udo Hoffmann, Maros Ferencik et al. Circulation profile →
  17. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment
    2020 216 citations Steven R. Goldsmith, Faı̈ez Zannad et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Udelson United States 80 20.0k 6.9k 5.5k 2.9k 2.8k 326 25.9k
Sherif F. Nagueh United States 73 28.3k 1.4× 10.6k 1.5× 4.7k 0.9× 3.6k 1.2× 1.8k 0.6× 241 32.1k
Otto A. Smiseth Norway 61 27.1k 1.4× 10.5k 1.5× 4.7k 0.8× 3.4k 1.2× 1.3k 0.5× 241 30.2k
Thor Edvardsen Norway 70 22.2k 1.1× 9.8k 1.4× 4.8k 0.9× 2.6k 0.9× 1.3k 0.5× 383 25.6k
Anthony N. DeMaria United States 70 18.2k 0.9× 8.4k 1.2× 8.7k 1.6× 3.5k 1.2× 1.8k 0.6× 462 26.5k
David O. Hodge United States 79 12.9k 0.6× 9.0k 1.3× 4.2k 0.8× 2.1k 0.7× 1.4k 0.5× 640 27.2k
Laura Ernande France 20 17.3k 0.9× 5.3k 0.8× 3.4k 0.6× 3.7k 1.3× 1.1k 0.4× 35 20.2k
Martin St. John Sutton United States 45 18.6k 0.9× 4.7k 0.7× 3.9k 0.7× 2.9k 1.0× 1.1k 0.4× 161 21.7k
Thierry Gillebert Belgium 48 15.8k 0.8× 5.1k 0.7× 2.7k 0.5× 2.2k 0.8× 1.3k 0.5× 138 19.2k
Paul Grayburn United States 73 19.3k 1.0× 5.2k 0.8× 7.4k 1.3× 2.9k 1.0× 1.5k 0.5× 362 24.5k
Paolo Marino Italy 44 17.5k 0.9× 5.9k 0.9× 4.1k 0.7× 2.3k 0.8× 889 0.3× 272 20.7k

Countries citing papers authored by James E. Udelson

Since Specialization
Citations

This map shows the geographic impact of James E. Udelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Udelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Udelson more than expected).

Fields of papers citing papers by James E. Udelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Udelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Udelson. The network helps show where James E. Udelson may publish in the future.

Co-authorship network of co-authors of James E. Udelson

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Udelson. A scholar is included among the top collaborators of James E. Udelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Udelson. James E. Udelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waha, Suzanne de, Manesh R. Patel, Hölger Thiele, et al.. (2024). Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 13(18). e034748–e034748. 5 indexed citations
2.
Konstam, Marvin A., James E. Udelson, Douglas L. Mann, et al.. (2024). Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results. Journal of Cardiac Failure. 30(1). 313–313. 2 indexed citations
3.
Udelson, James E., Colin M. Barker, Gerard Wilkins, et al.. (2023). No-Implant Interatrial Shunt for HFpEF. JACC Heart Failure. 11(8). 1121–1130. 14 indexed citations
4.
Udelson, James E., Harry P. Selker, & Eugene Braunwald. (2022). Glucose–Insulin–Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook. Circulation. 146(7). 503–505. 9 indexed citations
5.
Redfors, Björn, Reza Mohebi, Gennaro Giustino, et al.. (2021). Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction. Circulation Cardiovascular Interventions. 14(2). e009879–e009879. 34 indexed citations
6.
Tini, Giacomo, Antonio Cannatà, Marco Canepa, et al.. (2021). Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?. Heart Failure Reviews. 27(2). 587–594. 8 indexed citations
7.
Goldsmith, Steven R., James E. Udelson, & Mihai Gheorghiade. (2018). Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure?. Journal of Cardiac Failure. 24(2). 112–114. 8 indexed citations
8.
Adamson, Philip D, Christopher B. Fordyce, David McAllister, et al.. (2017). Identification of patients with stable chest pain deriving minimal value from coronary computed tomography angiography: An external validation of the PROMISE minimal-risk tool. International Journal of Cardiology. 252. 31–34. 19 indexed citations
9.
Bittner, Daniel O., Thomas Mayrhofer, Fabian Bamberg, et al.. (2017). Impact of Coronary Calcification on Clinical Management in Patients With Acute Chest Pain. Circulation Cardiovascular Imaging. 10(5). 18 indexed citations
10.
Daubert, Melissa A., Eric Yow, G. Dewey Dunn, et al.. (2017). Novel Mitochondria-Targeting Peptide in Heart Failure Treatment. Circulation Heart Failure. 10(12). 133 indexed citations
11.
Vaduganathan, Muthiah, Robert J. Mentz, Haris Subačius, et al.. (2017). Abstract 20769: Sudden Cardiac Death Risk After Hospitalization for Heart Failure: Insights From EVEREST. Circulation. 1 indexed citations
12.
Maron, Martin S., Raymond H. Chan, Adam P. McGraw, et al.. (2013). Abstract 16910: Can Spironolactone Mitigate Myocardial Fibrosis and Alter Sudden Death Risk and Heart Failure Symptoms in Patients With Hypertrophic Cardiomyopathy?: A Prospective, Randomized Trial. Circulation. 128. 5 indexed citations
13.
Mentz, Robert J., Bradley D. Allen, Mary Kwasny, et al.. (2012). Influence of Documented History of Coronary Artery Disease on Outcomes in Patients Admitted for Worsening Heart Failure with Reduced Ejection Fraction in the EVEREST Trial. European Journal of Heart Failure. 15(1). 61–68. 20 indexed citations
14.
Maron, Martin S., Iacopo Olivotto, Caitlin Harrigan, et al.. (2011). Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy. Circulation. 124(1). 40–47. 285 indexed citations
15.
Kramer, Daniel G., et al.. (2010). Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction. Journal of the American College of Cardiology. 56(5). 392–406. 341 indexed citations
16.
Douglas, Pamela S., Allen J. Taylor, Diane E. Bild, et al.. (2009). Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute. Journal of cardiovascular computed tomography. 3(4). 212–223. 8 indexed citations
17.
Senior, Roxy, Miguel Zabalgoitia, Mark Monaghan, et al.. (2007). Abstract 2479: Accurate Detection of Coronary Artery Disease by Echocardiography using Perflubutane Polymer Microspheres, a Novel Contrast Agent: Comparison with Nuclear Perfusion Imaging in Two Phase Three Multicenter Clinical Trials. Circulation. 116. 4 indexed citations
18.
Dilsizian, Vasken, Timothy M. Bateman, Steven R. Bergmann, et al.. (2005). Metabolic Imaging With β-Methyl- p -[ 123 I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia. Circulation. 112(14). 2169–2174. 146 indexed citations
19.
Patel, Ayan R., Jeffrey T. Kuvin, Kathleen A. Sliney, et al.. (2005). Gender-Based Differences in Brachial Artery Flow-Mediated Vasodilation as an Indicator of Significant Coronary Artery Disease. The American Journal of Cardiology. 96(9). 1223–1226. 17 indexed citations
20.
Salem, Deeb N., Natesa G. Pandian, & James E. Udelson. (1990). Percutaneous Balloon Valvuloplasty and Coronary Angioplasty: What Kind of Guidance Would be Useful During the Performance of These Procedures?. Echocardiography. 7(4). 397–402. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherif F. Nagueh Breakdown of academic impact, for papers by Otto A. Smiseth Breakdown of academic impact, for papers by Thor Edvardsen Breakdown of academic impact, for papers by Anthony N. DeMaria Breakdown of academic impact, for papers by David O. Hodge Breakdown of academic impact, for papers by Laura Ernande Breakdown of academic impact, for papers by Martin St. John Sutton Breakdown of academic impact, for papers by Thierry Gillebert Breakdown of academic impact, for papers by Paul Grayburn Breakdown of academic impact, for papers by Paolo Marino
Rankless by CCL
2026